Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
15 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250515683206/en/QurAlis-Announces-Exclusive-License-on-Novel-Mechanism-for-Fragile-X-Syndrome-FXS-to-Enable-Development-of-First-Potential-Disease-Modifying-Therapy
12 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/quralis-announces-topline-data-from-its-phase-1-clinical-trial-of-qrl-101-evaluating-biomarkers-of-als-and-epilepsy-in-healthy-volunteers-302399085.html
19 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/quralis-anqur-clinical-trial-of-qrl-201-in-als-advances-to-dose-range-finding-drf-phase-with-first-participant-dosed-302307803.html
11 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/quralis-expands-leadership-team-with-doug-williamson-md-as-chief-medical-officer-and-jason-brown-mba-as-chief-financial-officer-and-appoints-shafique-virani-md-to-board-of-directors-302166686.html
03 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/quralis-grants-lilly-exclusive-global-license-for-qrl-204-a-potentially-first-in-class-precision-therapy-that-restores-unc13a-function-in-als-and-ftd-302156943.html
06 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/quralis-to-present-data-showing-link-between-tdp-43-pathology-and-role-of-unc13a-in-neuronal-biology-related-to-als-and-other-neurodegenerative-diseases-301917970.html
ABOUT THIS PAGE